| Autor: |
Brook AD; Albert Einstein College of Medicine, Bronx, New York, USA andrew.brook@einsteinmed.edu., Clerk-Lamalice O; Interventional Spine Service, Beam Interventional & Diagnostic Imaging, Calgary, Alberta, Canada., De Leacy RA; Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Brook AL; Interventional Neuroradiology, Montefiore Medical center, Bronx, New York, USA., Hirsch JA; NeuroEndovascular Program, Massachusetts General Hospital, Boston, Massachusetts, USA. |
| Abstrakt: |
Competing Interests: Competing interests: OC – Consultant: Stryker, Medtronic, Medical Metrics, Simplify Medical, Regeltec, SpinaFx. Research Funding: Medical Metrics, Konica Minolta. Advisory Board: Regeltec, SpinaFx. RDL – Consultant: Stryker IVS, Stryker Neurovascular, Cerenovus, Imperative Care, Hyprevention, Scientia Vascular Research support: Kaneka medical, Siemens Healthineers, Hyprevention, SNIS foundation Equity: Synchron, Endostream, Borvo, Vastrax, Von Vascular, Q’Apel, Radical Catheter. ALB –Consultant: NEVRO, Medtronic, VIZ.AI, Boston Scientific. JH – Chair Health Policy Committee SNIS, Deputy Editor JNIS. Consultant: Medtronic, Relievant, VIZ.AI, Sanofi, Cerenovus. DMSB Chair: Balt, Rapid Medical, ArsenalGrant recipient: Neiman Health Policy Institute. |
